Eam Investors, LLC Morphic Holding, Inc. Transaction History

Eam Investors, LLC

  • $569 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$34.33 - $62.11 $1.15 Million - $2.08 Million
33,449 New
33,449 $1.92 Million
Q4 2021

Feb 11, 2022
SELL
$43.27 - $65.72 $992,310 - $1.51 Million
-22,933 Closed
0 $0
Q1 2021

May 11, 2021
BUY
$29.77 - $84.85 $682,715 - $1.95 Million
22,933 New
22,933 $1.45 Million

Others Institutions Holding MORF

# of Institutions
142
Shares Held
37.9M
Call Options Held
13.5K
Put Options Held
190K
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $1.31B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email